- Accesswire•2 months agoMedifocus, Inc. Announces Significant Improvement in Operating Results for the Six Months Ended September 30, 2016
COLUMBIA, MD / ACCESSWIRE / December 19, 2016 / Medifocus, Inc. (OTCQX: MDFZF and TSXV: MFS) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products ...
- PR Newswire•5 months ago
COLUMBIA, MD, Oct. 3, 2016 /PRNewswire/ - Medifocus, Inc. (OTCQX:MDFZF and TSXV:MFS.V) ("Medifocus" or the "Company"), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, today announced the appointment of William Jow, M.D. to the position of Chief Executive Officer, effective October 1, 2016, replacing Augustine Y. Cheung, Ph.D., the founder of the Company. "We thank Dr. Cheung for his service at Medifocus and wish Dr. Cheung the best in the next phase of his career." said Mr. Grant Walsh, Chairman of the Board of Directors.
- CNW Group•5 months ago
Medifocus Inc. Announces Appointment of New Chief Executive Officer
MFS.V : Summary for MEDIFOCUS INC - Yahoo Finance
Medifocus Inc. (MFS.V)
TSXV - TSXV Delayed Price. Currency in CAD
Add to watchlist
|Day's Range||0.02 - 0.02|
|52 Week Range||0.01 - 0.05|
|PE Ratio (TTM)||-0.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|